# Benitec Biopharma Inc.: Form 8-K, filed Apr 19, 2024

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: 8-K
- Filed: 2024-04-19
- Accepted by EDGAR: Apr 18, 2024, 21:45 ET
- Period: 2024-04-17
- Accession: 0001193125-24-101289
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524101289/d826712d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000119312524101289/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000119312524101289/d826712d8k.htm

Filed Apr 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-101289. Last ingested by Listed: Nov 14, 2026, 11:28 ET. No prices; not investment advice.
